|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
NCI - Center for Cancer Research-Medical Oncology National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00018915 |
Purpose
RATIONALE: Children with cancer who go camping with other patients may have improved quality of life, self-esteem, and relationships with parents, family, and peers.
PURPOSE: Clinical trial to study the psychological benefits of a 1-week camping trip for children with cancer.
| Condition | Intervention |
|
Cancer-Related Problem/Condition Unspecified Childhood Solid Tumor, Protocol Specific |
Procedure: psychosocial assessment and care Procedure: quality-of-life assessment |
| MedlinePlus related topics: | Cancer |
| Study Type: | Interventional |
| Study Design: | Other |
| Official Title: | Psychological Benefits of a "Normalized" Camping Experience for Children With Cancer |
| Estimated Enrollment: | 9999 |
| Study Start Date: | March 1983 |
OBJECTIVES:
OUTLINE: Patients participate in a full range of age appropriate activities and undergo observation during an enriched, normalized camping experience for 1 week. Patients and their family members undergo psychosocial interviews and patients complete psychological questionnaires before, during, and after the camping experience. Medical care continues to be provided according to the plan formulated between the patient's home medical team and the NIH-based medical team.
Quality of life is assessed.
PROJECTED ACCRUAL: Approximately 9,999 patients will be accrued for this study.
Eligibility
| Ages Eligible for Study: | 7 Years to 17 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of cancer
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Other:
Contacts and Locations| United States, Maryland | |||||
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting | ||||
| Bethesda, Maryland, United States, 20892-1182 | |||||
| Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 | |||||
| NCI - Center for Cancer Research-Medical Oncology |
| National Cancer Institute (NCI) |
| Study Chair: | Stephen J. Chanock, MD | National Cancer Institute (NCI) |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000074606, NCI-83-C-0022F, NCI-T83-1094N |
| First Received: | July 11, 2001 |
| Last Updated: | October 18, 2008 |
| ClinicalTrials.gov Identifier: | NCT00018915 |
| Health Authority: | Unspecified |
|
|